Ethyl 2-(2-bromobenzo[d]thiazol-6-yl)acetate, 97%, 1g

AKT Inhibitor VIII, >97.0%(HPLC), 25mg

2-{[(2-Hydroxyethyl)thio]methyl}quinazolin-4-ol, 97.0%, 1g

N-Acetylneuraminic Acid>98.0%(T)(HPLC)100mg

[(1-isopropyl-1H-pyrazol-4-yl)methyl]amine hydrochloride, 95.0%, 250mg

7-Bromo-4,6-dichloroquinazoline, 95.0%, 1g

4-(tert-Butyl)-2-phenylpyridine, 95.0%, 10g

2-Fluoro-4-methylpyridine-5-boronic acid, 97.0%, 1g

[(4-chloro-3-fluorophenyl)methyl](methyl)amine, 95%, 100mg

4-Bromo-2,6-dimethylaniline, 99.00%, 10g

1-(2-chloro-5-nitrophenyl)-3-(ethoxycarbonyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

Bis(4-phenylphenyl)phosphine oxide, 97%, 1g

2-(4-Isobutylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 25g